Search Count: 13
 |
Crystal Structure Of E. Coli Fabi In Complex With Nad And (R,E)-3-(7-Amino-8-Oxo-6,7,8,9-Tetrahydro-5H-Pyrido[2,3-B]Azepin-3-Yl)-N-Methyl-N-((3-Methylbenzofuran-2-Yl)Methyl)Acrylamide
Organism: Escherichia coli str. k-12 substr. mg1655
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2023-02-15 Classification: ANTIBIOTIC Ligands: NAD, NQF |
Organism: Escherichia coli str. k-12 substr. mg1655
Method: X-RAY DIFFRACTION
Release Date: 2023-02-15
Ligands: NAD, NQF
 |
Crystal Structure Of Acinetobacter Baumannii Fabi In Complex With Nad And (R,E)-3-(7-Amino-8-Oxo-6,7,8,9-Tetrahydro-5H-Pyrido[2,3-B]Azepin-3-Yl)-N-Methyl-N-((3-Methylbenzofuran-2-Yl)Methyl)Acrylamide
Organism: Acinetobacter baumannii atcc 19606 = cip 70.34 = jcm 6841
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2023-02-15 Classification: ANTIBIOTIC Ligands: NQF, NAD |
Organism: Acinetobacter baumannii atcc 19606 = cip 70.34 = jcm 6841
Method: X-RAY DIFFRACTION
Release Date: 2023-02-15
Ligands: NQF, NAD
 |
Crystal Structure Of Acinetobacter Baumannii Fabi In Complex With Nad And Fabimycin ((S,E)-3-(7-Amino-8-Oxo-6,7,8,9-Tetrahydro-5H-Pyrido[2,3-B]Azepin-3-Yl)-N-Methyl-N-((3-Methylbenzofuran-2-Yl)Methyl)Acrylamide)
Organism: Acinetobacter baumannii atcc 19606 = cip 70.34 = jcm 6841
Method: X-RAY DIFFRACTION Resolution:2.74 Å Release Date: 2023-02-15 Classification: ANTIBIOTIC Ligands: NAD, NUC |
Organism: Acinetobacter baumannii atcc 19606 = cip 70.34 = jcm 6841
Method: X-RAY DIFFRACTION
Release Date: 2023-02-15
Ligands: NAD, NUC
 |
Crystal Structure Of E. Coli Fabi In Complex With Nad And Fabimycin ((S,E)-3-(7-Amino-8-Oxo-6,7,8,9-Tetrahydro-5H-Pyrido[2,3-B]Azepin-3-Yl)-N-Methyl-N-((3-Methylbenzofuran-2-Yl)Methyl)Acrylamide)
Organism: Escherichia coli str. k-12 substr. mg1655
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2022-12-14 Classification: ANTIBIOTIC Ligands: NAD, NUC |
Organism: Escherichia coli str. k-12 substr. mg1655
Method: X-RAY DIFFRACTION
Release Date: 2022-12-14
Ligands: NAD, NUC
 |
Crystal Structure Of Human Shoc2: A Leucine-Rich Repeat Protein
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2022-05-04 Classification: STRUCTURAL PROTEIN Ligands: MG, NO3 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-05-04
Ligands: MG, NO3
 |
Cryo-Em Structure Of Shoc2-Pp1C-Mras Holophosphatase Complex
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2022-05-04 Classification: CELL CYCLE Ligands: GTP, MG, MN, CL |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2022-05-04
Ligands: GTP, MG, MN, CL
 |
Mycobacterium Tuberculosis Dihydrofolate Reductase Complexed With Beta-Nadph And 3'-[(2R)-4-(2,4-Diamino-6-Ethylpyrimidin-5-Yl)But-3-Yn-2-Yl]-5'-Methoxy[1,1'-Biphenyl]-4-Carboxylic Acid
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2018-05-23 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NDP, G6Y |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2018-05-23
Ligands: NDP, G6Y
 |
Mycobacterium Tuberculosis Dihydrofolate Reductase Complexed With Beta-Nadph And 4-[3-[3-[2,4-Bis(Azanyl)-6-Ethyl-Pyrimidin-5-Yl]Prop-2-Ynyl]-5-Methoxy-Phenyl]Benzoic Acid
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2018-05-23 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NDP, U75, ACT, NA, GOL |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2018-05-23
Ligands: NDP, U75, ACT, NA, GOL
 |
Mycobacterium Tuberculosis Dihydrofolate Reductase Complexed With Beta-Nadph And N-(4-{[(2-Amino-4-Oxo-3,4-Dihydropteridin-6-Yl)Methyl]Amino}-2-Hydroxybenzene-1-Carbonyl)-L-Glutamic Acid
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2018-05-23 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NDP, G7D, GOL, SO4 |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2018-05-23
Ligands: NDP, G7D, GOL, SO4
 |
Homo Sapiens Dihydrofolate Reductase Complexed With Beta-Nadph And 3'-[(2R)-4-(2,4-Diamino-6-Ethylphenyl)But-3-Yn-2-Yl]-5'-Methoxy-[1,1'-Biphenyl]-4-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2018-05-23 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NDP, G6Y, CL, GOL, EOH, CA, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-23
Ligands: NDP, G6Y, CL, GOL, EOH, CA, SO4
 |
Mycobacterium Tuberculosis Rv2671 Complexed With Beta-Nadph And 6-Ethyl-5-{(3S)-3-[2-Methoxy-5-(Pyridin-4-Yl)Phenyl]But-1-Yn-1-Yl}Pyrimidine-2,4-Diamine
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2018-05-23 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NDP, G8J |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2018-05-23
Ligands: NDP, G8J
 |
Staphylococcus Aureus Dihydrofolate Reductase Complexed With Beta-Nadph And Ucp1191
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2017-04-19 Classification: OXIDOREDUCTASE Ligands: UC9, NAP |
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION
Release Date: 2017-04-19
Ligands: UC9, NAP
 |
Mycobacterium Tuberculosis Dihydrofolate Reductase Complexed With Beta- Nadph And 3'-(3-(2,4-Diamino-6-Ethylpyrimidin-5-Yl)Prop-2-Yn-1-Yl)-4'-Methoxy-[1,1'-B Iphenyl]-4-Carboxylic Acid (Ucp1106)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2016-08-24 Classification: OXIDOREDUCTASE Ligands: NDP, U06 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2016-08-24
Ligands: NDP, U06